Growth factor plus preemptive (‘just-in-time’) plerixafor successfully mobilizes hematopoietic stem cells in multiple myeloma patients despite prior lenalidomide exposure
Year: 2012
Type: article
Study design: Observational Study
Source: Bone Marrow Transplantation
DOI: 10.1038/bmt.2012.60
Institution: Medical University of South Carolina
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2013741276